Find a
  WATCHMAN  
Implanter

WATCHMAN DELIVERS POSITIVE RESULTS IN CLINICAL TRIALS


  • WATCHMAN is a safe alternative to long-term warfarin therapy which offers comparable stroke risk reduction and enables patients to stop taking long-term warfarin
  • Long term data from PROTECT AF and PREVAIL demonstrated that WATCHMAN also offered statistically significant reductions in disabling stroke, non-procedure related major bleeding and mortality compared to long-term warfarin, after 5 years of follow-up1

PROVEN PROCEDURE


Learn about the efficacy results of WATCHMAN compared to warfarin in clinical trials of patients with non-valvular atrial fibrillation (NVAF) who have a reason to seek an alternative to OACs

PROVEN SAFETY


Review safety data from the clinical studies as well as real-world results from the initial US commercial experience, showing overall high implant success rates for WATCHMAN.

Reference:
1. Reddy VY, Doshi SK, Kar S, et al. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J. Am Coll Cardiol. 2017; In Press.

 

Follow Us: Twitter LinkedIn YouTube Google+
Top